STAAR Surgical Company (STAA) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-101.1%

-$0.28

vs $24.94 price

Levered DCF

$2.17

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

7.99

Safe zone

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-14.57×	-59.05×	70.93×	58.48×	175.58×	609.38×	107.44×	284.18×
P/B	3.4×	2.99×	3.92×	6.93×	16.67×	18.32×	9.57×	10.66×
P/S	4.89×	3.79×	4.7×	8.19×	18.7×	22.1×	10.19×	11.39×
EV / EBITDA	-14.27×	-501.57×	35.22×	45.42×	118.41×	351.9×	91.26×	144.97×
Gross margin	76.2%	76.3%	78.4%	78.5%	77.5%	72.4%	74.5%	73.8%
Operating margin	-19.2%	-4.0%	8.7%	15.4%	14.5%	4.1%	7.9%	5.3%
Net margin	-33.6%	-6.4%	6.6%	13.9%	11.9%	3.6%	9.4%	4.0%
Current ratio	4.55×	5.23×	5.62×	6.03×	5.56×	5.25×	5.07×	5.47×
Debt / equity	0.11×	0.1×	0.09×	0.09×	0.12×	0.05×	0.06×	0.04×
Interest coverage	0×	0×	0×	0×	877.34×	0×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-23.4%	-5.1%	5.5%	11.8%	10.6%	3.0%	8.8%	3.8%
Return on invested capital	-11.3%	-2.8%	4.2%	10.3%	9.8%	2.2%	6.7%	3.4%
Return on assets	-17.4%	-4.0%	4.4%	9.5%	8.0%	2.3%	6.8%	3.0%
Free cash flow yield	-3.4%	-0.6%	-0.2%	0.8%	0.7%	0.3%	1.0%	0.7%
Earnings yield	-6.9%	-1.7%	1.4%	1.7%	0.6%	0.2%	0.9%	0.4%
Enterprise value	$1.1B	$1.1B	$1.4B	$2.3B	$4.1B	$3.5B	$1.4B	$1.3B
Net debt / EBITDA	1.55×	48.78×	-3.79×	-1.11×	-4.79×	-14.36×	-7.1×	-10.88×
Cash conversion cycle (days)	364	223	224	160	134	202	166	191